Millennium Management
LUMO

Millennium Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Millennium Management’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-22,222
Closed -$2.04M – 4141
2017
Q3 		$2.04M Buy
+22,222
New +$1.7M ﹤0.01% 2158
2016
Q3 		– Sell
-6,667
Closed -$676K – 3689
2016
Q2 		$676K Buy
+6,667
New +$826K ﹤0.01% 2344
2014
Q4 		– Sell
-29,778
Closed -$5.74M – 4339
2014
Q3 		$5.74M Buy
29,778
+8,222
+38% +$1.81M 0.01% 1203
2014
Q2 		$5.15M Buy
+21,556
New +$4.38M 0.01% 1199

Other funds holding LUMO

PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
GWM
Greenwich Wealth Management Greenwich, Connecticut $2.45B AUM 39.53% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Millennium Management's LUMO Position: Q3 2024 in Review

Millennium Management sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q3 2024, closing a stake of 37,018 shares — an estimated $85.9K sold.

Millennium Management first reported a position in LUMO in Q2 2013 and held it in 31 quarters. The position peaked at $19M in Q4 2017. 28 funds tracked by Wall St. Rank hold LUMO as of Q3 2024.

  • Millennium Management reported no remaining Lumos Pharma, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Millennium Management sold 37,018 Lumos Pharma, Inc. Common Stock shares in Q3 2024, an estimated $85.9K.
  • Millennium Management first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and held it in 31 quarters.
  • Millennium Management's Lumos Pharma, Inc. Common Stock position peaked at $19M in Q4 2017.
  • 28 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2024.

Based on Millennium Management's 13F filing for Q3 2024, filed 14 Nov 2024.